Literature DB >> 9706055

Rate control in transdermal beta-estradiol reservoir membrane systems: the role of membrane and adhesive layer.

R Altenburger1, U D Rohr, T Kissel.   

Abstract

PURPOSE: The aim of our study was to clarify the kinetic performance of a membrane controlled reservoir system (MCRS) for beta-estradiol (E2) under in vitro conditions by determination of the role of membrane and adhesive layer on E2 flux control.
METHODS: E2 and ethanol fluxes across EVA membrane or membrane coated with adhesive from saturated solutions in defined ethanol/PBS mixtures were measured in the symmetric and asymmetric configuration. Physicochemical parameters of the EVA membrane were determined.
RESULTS: The E2 flux across the 9% EVA membrane steadily increased with increasing ethanol concentrations in both configurations, due to enhanced uptake of E2 by the polymer and increasing membrane diffusivity. Permeation across the EVA membrane coated with an adhesive layer in symmetric and asymmetric configuration increased up to maximum values of 0.80+/-0.14 micrograms X cm-2 X h-1 and 0.37+/-0.02 micrograms X cm-2 X h-1, respectively, at 62.5% (v/v) ethanol. The fluxes then decreased with further increase in the volume fraction of ethanol due to a dramatically reduced permeability of the adhesive layer. For the asymmetric case, a linear dependence of E2 on the ethanol fluxes was observed.
CONCLUSIONS: The E2 flux from MCRS is strictly dependent on reservoir ethanol concentrations, whereas the adhesive layer represents the rate controlling barrier at high ethanol levels (> 70% v/v).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9706055     DOI: 10.1023/a:1011944025262

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

1.  Cotransport of estradiol and ethanol through human skin in vitro: understanding the permeant/enhancer flux relationship.

Authors:  P Liu; T Kurihara-Bergstrom; W R Good
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

2.  Bioavailability of estradiol from two transdermal patches.

Authors:  I Setnikar; L C Rovati; B Vens-Cappell; C Hilgenstock
Journal:  Arzneimittelforschung       Date:  1996-03

3.  Percutaneous absorption enhancement of an ionic molecule by ethanol-water systems in human skin.

Authors:  T Kurihara-Bergstrom; K Knutson; L J DeNoble; C Y Goates
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

Review 4.  Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints.

Authors:  J A Balfour; R C Heel
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

5.  Disparity of in vitro and in vivo oleic acid-enhanced beta-estradiol percutaneous absorption across human skin.

Authors:  L K Pershing; G E Parry; L D Lambert
Journal:  Pharm Res       Date:  1993-12       Impact factor: 4.200

6.  Clinical experience with a seven-day estradiol transdermal system for estrogen replacement therapy.

Authors:  S F Gordon
Journal:  Am J Obstet Gynecol       Date:  1995-09       Impact factor: 8.661

7.  Ethanol:water mutually enhanced transdermal therapeutic system. I: Nitroglycerin solution properties and membrane transport.

Authors:  B Berner; J H Otte; G C Mazzenga; R J Steffens; C D Ebert
Journal:  J Pharm Sci       Date:  1989-04       Impact factor: 3.534

8.  Mechanism of ethanol-enhanced estradiol permeation across human skin in vivo.

Authors:  L K Pershing; L D Lambert; K Knutson
Journal:  Pharm Res       Date:  1990-02       Impact factor: 4.200

9.  Bioavailability Study of Menorest®, a New Estrogen Transdermal Delivery System, Compared with a Transdermal Reservoir System.

Authors:  Y Le Roux; M L Borg; M Sibille; J Thebault; A Renoux; M J Douin; F Djebbar; M P Dain
Journal:  Clin Drug Investig       Date:  1995-09       Impact factor: 2.859

10.  Effects of vehicle supplementation on total estradiol absorption from a transdermal estradiol delivery system.

Authors:  R D Smith; D E Robinson; B Delignieres; B D Albertson; T P Tomai; M J Zinaman; J A Simon
Journal:  Fertil Steril       Date:  1991-12       Impact factor: 7.329

View more
  1 in total

1.  Biotransformation of estradiol in the human keratinocyte cell line HaCaT: metabolism kinetics and the inhibitory effect of ethanol.

Authors:  R Altenburger; T Kissel
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.